Biden Covid officials scramble to plan for Omicron subvariant threat
New strains seem to evade treatments used for vulnerable patients — and could complicate the latest White House messaging strategy on Covid.
Today's Liberal News
By Adam Cancryn and Erin Banco
Biden Covid officials scramble to plan for Omicron subvariant threat
New strains seem to evade treatments used for vulnerable patients — and could complicate the latest White House messaging strategy on Covid.
Biden Covid officials scramble to plan for Omicron subvariant threat
New strains seem to evade treatments used for vulnerable patients — and could complicate the latest White House messaging strategy on Covid.
Biden Covid officials scramble to plan for Omicron subvariant threat
New strains seem to evade treatments used for vulnerable patients — and could complicate the latest White House messaging strategy on Covid.
Biden’s Operation Warp Speed revival stumbles out of the gate
The administration’s plans to create a new accelerator for Covid vaccines and treatments has hit a wall.
Biden’s Operation Warp Speed revival stumbles out of the gate
The administration’s plans to create a new accelerator for Covid vaccines and treatments has hit a wall.
Biden’s Operation Warp Speed revival stumbles out of the gate
The administration’s plans to create a new accelerator for Covid vaccines and treatments has hit a wall.
Biden’s Operation Warp Speed revival stumbles out of the gate
The administration’s plans to create a new accelerator for Covid vaccines and treatments has hit a wall.
Biden’s Operation Warp Speed revival stumbles out of the gate
The administration’s plans to create a new accelerator for Covid vaccines and treatments has hit a wall.
Biden’s Operation Warp Speed revival stumbles out of the gate
The administration’s plans to create a new accelerator for Covid vaccines and treatments has hit a wall.
Biden administration eyeing booster shot recommendation within weeks
An additional dose for those 65 or older is under consideration. But there is concern about moving ahead of the normal FDA process.
Biden administration eyeing booster shot recommendation within weeks
An additional dose for those 65 or older is under consideration. But there is concern about moving ahead of the normal FDA process.
FDA approval of Pfizer Covid shot could come next week
The decision would apply to people 16 and older. Officials hope it will convince some vaccine holdouts to get inoculated.
FDA approval of Pfizer Covid shot could come next week
The decision would apply to people 16 and older. Officials hope it will convince some vaccine holdouts to get inoculated.
FDA approval of Pfizer Covid shot could come next week
The decision would apply to people 16 and older. Officials hope it will convince some vaccine holdouts to get inoculated.
FDA approval of Pfizer Covid shot could come next week
The decision would apply to people 16 and older. Officials hope it will convince some vaccine holdouts to get inoculated.
CDC’s second-in-command Anne Schuchat to step down
Her decision reportedly comes after clashes with agency director Rochelle Walensky.
CDC’s second-in-command Anne Schuchat to step down
Her decision reportedly comes after clashes with agency director Rochelle Walensky.
CDC’s second-in-command Anne Schuchat to step down
Her decision reportedly comes after clashes with agency director Rochelle Walensky.
CDC’s second-in-command Anne Schuchat to step down
Her decision reportedly comes after clashes with agency director Rochelle Walensky.
CDC’s second-in-command Anne Schuchat to step down
Her decision reportedly comes after clashes with agency director Rochelle Walensky.
CDC’s second-in-command Anne Schuchat to step down
Her decision reportedly comes after clashes with agency director Rochelle Walensky.